• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

随机对照试验与对比队列研究在验证淋巴结切除术在子宫内膜癌中的治疗作用。

Randomized controlled trial versus comparative cohort study in verifying the therapeutic role of lymphadenectomy in endometrial cancer.

机构信息

Division of Gynecologic Oncology, National Hospital Organization, Hokkaido Cancer Center, 4-2 Kikusui, Shiroishi-ku, Sapporo, 003-0804, Japan.

出版信息

Int J Clin Oncol. 2013 Apr;18(2):200-6. doi: 10.1007/s10147-012-0499-0. Epub 2012 Dec 1.

DOI:10.1007/s10147-012-0499-0
PMID:23203151
Abstract

A consensus regarding the therapeutic role of lymphadenectomy in endometrial cancer has not been reached because of conflicting negative results of randomized controlled trials and positive results of a cohort study. Since the effects of new treatments tend to be overestimated in observational studies, positive results of an observational study should be validated by a future trial. However, special difficulties are presented in randomized controlled trials in surgery. External validity is important for guaranteeing the reliability of a result of the trial. Physicians' recruitment of eligible patients into a trial depends on the confidence of those physicians for a surgical procedure, workplace environment and feelings of personal responsibility relevant to patients' risk of recurrence. When two surgical procedures are compared in a randomized controlled trial, technical quality control may be reduced in the complicated surgery group due to experienced surgeons' non-participation. It is highly possible that the recruitment issue is a threat to external validity. Therefore, a randomized controlled trial may not be the best format for demonstrating the full benefits of complicated surgery. Multiple studies have demonstrated that the results of well-designed observational studies can be reliable and are comparable with those of randomized controlled trials. Journal editors and funding sources are requested to become more generous with observational studies, especially prospective cohort studies.

摘要

由于随机对照试验的结果相互矛盾,且队列研究的结果为阳性,因此对于淋巴结切除术在子宫内膜癌中的治疗作用尚未达成共识。由于新疗法的疗效在观察性研究中往往被高估,因此需要通过未来的试验来验证观察性研究的阳性结果。然而,手术中的随机对照试验存在特殊的困难。外部有效性对于保证试验结果的可靠性很重要。医生是否将符合条件的患者招募到试验中取决于他们对手术程序的信心、工作场所环境以及与患者复发风险相关的个人责任感。当在随机对照试验中比较两种手术方法时,由于经验丰富的外科医生不参与,复杂手术组的技术质量控制可能会降低。招募问题很可能对外部有效性构成威胁。因此,随机对照试验可能不是展示复杂手术全部益处的最佳形式。多项研究表明,精心设计的观察性研究的结果是可靠的,并且可以与随机对照试验的结果相媲美。期刊编辑和资金来源应更加支持观察性研究,特别是前瞻性队列研究。

相似文献

1
Randomized controlled trial versus comparative cohort study in verifying the therapeutic role of lymphadenectomy in endometrial cancer.随机对照试验与对比队列研究在验证淋巴结切除术在子宫内膜癌中的治疗作用。
Int J Clin Oncol. 2013 Apr;18(2):200-6. doi: 10.1007/s10147-012-0499-0. Epub 2012 Dec 1.
2
Tailoring lymphadenectomy according to the risk of lymph node metastasis in endometrial cancer.根据子宫内膜癌淋巴结转移风险进行个体化淋巴结切除术。
J Obstet Gynaecol Res. 2014 Feb;40(2):317-21. doi: 10.1111/jog.12309.
3
Methodological considerations in the analysis of the therapeutic significance of lymphadenectomy in endometrial cancer.分析淋巴结切除术在子宫内膜癌治疗意义中的方法学考虑。
Taiwan J Obstet Gynecol. 2013 Mar;52(1):8-13. doi: 10.1016/j.tjog.2013.01.003.
4
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.比较前哨淋巴结活检与淋巴结切除术用于子宫内膜癌分期的研究(FIRES 试验):一项多中心、前瞻性、队列研究。
Lancet Oncol. 2017 Mar;18(3):384-392. doi: 10.1016/S1470-2045(17)30068-2. Epub 2017 Feb 1.
5
Stage IB endometrial cancer. Does lymphadenectomy replace adjuvant radiotherapy?ⅠB期子宫内膜癌。淋巴结切除术能否替代辅助放疗?
Strahlenther Onkol. 2007 Nov;183(11):600-4. doi: 10.1007/s00066-007-1801-3.
6
Systematic lymphadenectomy for survival in patients with endometrial cancer: a meta-analysis.系统淋巴结切除术治疗子宫内膜癌患者的生存获益:一项荟萃分析。
Jpn J Clin Oncol. 2012 May;42(5):405-12. doi: 10.1093/jjco/hys019. Epub 2012 Mar 6.
7
Lymphadenectomy in endometrial cancer: which is the right question?子宫内膜癌的淋巴结切除术:正确的问题是什么?
Int J Gynecol Cancer. 2010 Oct;20(11 Suppl 2):S52-4. doi: 10.1111/IGC.0b013e3181f60d0f.
8
Benefit of lymphadenectomy in endometrial cancer: can the truth be obtained by randomized controlled trial after ASTEC?子宫内膜癌淋巴结切除术的益处:在ASTEC研究之后,能否通过随机对照试验得出真相?
Int J Gynecol Cancer. 2009 Nov;19(8):1467. doi: 10.1111/IGC.0b013e3181b8d3ea.
9
The 10-year results after national introduction of pelvic lymph node staging in Danish intermediate-risk endometrial cancer patients not given postoperative radiotherapy.丹麦对未行术后放疗的中危子宫内膜癌患者进行盆腔淋巴结分期后的 10 年结果。
Eur J Obstet Gynecol Reprod Biol. 2021 Aug;263:239-246. doi: 10.1016/j.ejogrb.2021.06.040. Epub 2021 Jun 26.
10
Phase III trial to confirm the superiority of pelvic and para-aortic lymphadenectomy to pelvic lymphadenectomy alone for endometrial cancer: Japan Clinical Oncology Group Study 1412 (SEPAL-P3).一项旨在证实盆腔及腹主动脉旁淋巴结切除术相较于单纯盆腔淋巴结切除术治疗子宫内膜癌具有优越性的Ⅲ期试验:日本临床肿瘤学组研究1412(SEPAL-P3)
Jpn J Clin Oncol. 2017 Oct 1;47(10):986-990. doi: 10.1093/jjco/hyx108.

引用本文的文献

1
Two decades of surgical randomized controlled trials: worldwide trends in volume and methodological quality.二十年的外科随机对照试验:全球范围内的手术量和方法学质量趋势。
Br J Surg. 2023 Sep 6;110(10):1300-1308. doi: 10.1093/bjs/znad160.
2
Therapeutic significance of full lymphadenectomy in early-stage ovarian clear cell carcinoma.早期卵巢透明细胞癌行全面淋巴结切除术的治疗意义。
J Gynecol Oncol. 2018 Mar;29(2):e19. doi: 10.3802/jgo.2018.29.e19. Epub 2017 Dec 11.
3
FDG PET/CT diagnostic criteria may need adjustment based on MRI to estimate the presurgical risk of extrapelvic infiltration in patients with uterine endometrial cancer.

本文引用的文献

1
Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.子宫内膜癌:ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2011 Sep;22 Suppl 6:vi35-9. doi: 10.1093/annonc/mdr374.
2
Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis.腹主动脉旁淋巴结清扫术对子宫内膜癌患者生存效果的影响(SEPAL 研究):一项回顾性队列分析。
Lancet. 2010 Apr 3;375(9721):1165-72. doi: 10.1016/S0140-6736(09)62002-X. Epub 2010 Feb 24.
3
Meta-analysis of well-designed nonrandomized comparative studies of surgical procedures is as good as randomized controlled trials.
对于子宫内膜癌患者,氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描(FDG PET/CT)诊断标准可能需要根据磁共振成像(MRI)进行调整,以评估盆腔外浸润的术前风险。
Eur J Nucl Med Mol Imaging. 2015 Apr;42(5):676-84. doi: 10.1007/s00259-014-2964-7. Epub 2014 Dec 13.
4
Role of pelvic and para-aortic lymphadenectomy in endometrial cancer: current evidence.盆腔及腹主动脉旁淋巴结切除术在子宫内膜癌中的作用:当前证据
J Obstet Gynaecol Res. 2014 Feb;40(2):301-11. doi: 10.1111/jog.12344.
5
The role of para-aortic lymphadenectomy in endometrial cancer.腹主动脉旁淋巴结切除术在子宫内膜癌中的作用。
Int J Clin Oncol. 2013 Apr;18(2):193-9. doi: 10.1007/s10147-013-0528-7. Epub 2013 Feb 15.
手术操作的精心设计的非随机对照研究的荟萃分析与随机对照试验一样好。
J Clin Epidemiol. 2010 Mar;63(3):238-45. doi: 10.1016/j.jclinepi.2009.04.005. Epub 2009 Aug 27.
4
Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.子宫内膜癌系统性盆腔淋巴结清扫术的疗效(MRC ASTEC试验):一项随机研究
Lancet. 2009 Jan 10;373(9658):125-36. doi: 10.1016/S0140-6736(08)61766-3. Epub 2008 Dec 16.
5
Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.早期子宫内膜癌系统性盆腔淋巴结清扫术与未行淋巴结清扫术的比较:随机临床试验
J Natl Cancer Inst. 2008 Dec 3;100(23):1707-16. doi: 10.1093/jnci/djn397. Epub 2008 Nov 25.
6
Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging.子宫内膜癌淋巴转移的前瞻性评估:手术分期的范式转变
Gynecol Oncol. 2008 Apr;109(1):11-8. doi: 10.1016/j.ygyno.2008.01.023. Epub 2008 Mar 4.
7
Surgical and oncology trials for rectal cancer: who will participate?直肠癌的外科手术与肿瘤学试验:谁会参与?
Surgery. 2007 Jul;142(1):94-101. doi: 10.1016/j.surg.2007.01.013.
8
Non-entry of eligible patients into the Australasian Laparoscopic Colon Cancer Study.符合条件的患者未纳入澳大利亚腹腔镜结肠癌研究。
ANZ J Surg. 2006 Sep;76(9):825-9. doi: 10.1111/j.1445-2197.2006.03878.x.
9
External validity of randomised controlled trials: "to whom do the results of this trial apply?".随机对照试验的外部效度:“该试验结果适用于谁?”
Lancet. 2005;365(9453):82-93. doi: 10.1016/S0140-6736(04)17670-8.
10
Patient entry into randomized controlled trials of colorectal cancer treatment: factors influencing participation.患者参与结直肠癌治疗随机对照试验的情况:影响参与的因素
Surgery. 2003 Jun;133(6):608-13. doi: 10.1067/msy.2003.119.